thromboxanes has been researched along with Cardiovascular Stroke in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (61.82) | 18.7374 |
| 1990's | 15 (27.27) | 18.2507 |
| 2000's | 4 (7.27) | 29.6817 |
| 2010's | 2 (3.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäck, M | 1 |
| Abrosimova, KA; Sokolov, EI; Zykova, AA | 1 |
| Chin, YP; Hsu, CC; Lin, YL; Wang, TC | 1 |
| Kuzuya, T; Ohmori, M; Tada, M | 1 |
| Allen, PD; Hechtman, HB; Huval, WV; Lelcuk, S; Mannick, JA; Shepro, D | 1 |
| Gritsiuk, AI | 1 |
| Block, HU; Braun, H; Foerster, W; Hoffmann, W; Mest, HJ; Taube, C | 1 |
| Goldberg, S; Greenspon, A; Lebenthal, M; Lefer, AM; Smith, JB; Urban, P; Walinsky, P | 1 |
| Gréen, K; Vesterqvist, O | 1 |
| de Boer, AC; Genton, E; Turpie, AG | 1 |
| Gryglewski, RJ | 1 |
| Toivanen, J; Viinikka, L; Ylikorkala, O | 1 |
| Davi, G; Novo, S; Raineri, A; Strano, A; Traina, M | 1 |
| Castaldi, PA | 1 |
| Abbate, R; Gensini, GF; Masotti, G; Neri Serneri, GG; Poggesi, L | 1 |
| Hellstrom, HR | 1 |
| Kalkman, EA; Saxena, PR; Schoemaker, RG; van Dijk, JP; van Suylen, RJ | 1 |
| Förster, W; Parratt, JR | 1 |
| Beckmann, H; Dauben, HP; Elert, O; Gams, E; Keith, PR; Klein, M; Mayer, G; Schulte, HD | 1 |
| Corsini, G; Milani, M; Vetrano, A | 1 |
| Basili, S; Ciabattoni, G; Cipollone, F; Davì, G; Di Franco, M; Ferro, D; Roccaforte, S | 1 |
| Husted, SE; Jensen, HK; Kristensen, SD; Nielsen, HK; Vissinger, H; Ziegler, BK | 1 |
| Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S | 1 |
| Grodzińska, L; Gryglewski, RJ; Marcinkiewicz, E; Musiał, J; Serwońska, M; Szczeklik, A | 2 |
| Gryglewski, RJ; Moncada, S; Salmon, JA; Ubatuba, FB; Vane, JR; Weatherly, BC | 1 |
| Grodzínska, L; Gryglewski, RJ; Marcinkiewicz, E; Musiał, J; Serwónska, M; Szczeklik, A; Wójcik-Switek, L | 1 |
| Shalaev, SV | 1 |
| Chlewicka, I; Ignatowska-Switalska, H | 1 |
| Edhag, O; Gréen, K; Henriksson, P; Rasmanis, G; Vesterqvist, O | 3 |
| Khosseĭn Shakhavat, AF; Shelest, AN; Shushliapin, OI | 1 |
| Kolthay, E; Lusztig, G; Makáry, A; Mihai, K; Petö, J; Timár, S | 1 |
| Kaliman, J; O'Grady, J; Sinzinger, H | 1 |
| Fiedler, VB; Perzborn, E; Seuter, F | 2 |
| Assey, ME; Dorn, GW; Halushka, PV; Liel, N; Mais, DE; Trask, JL | 1 |
| Bleifeld, W; Hamm, CW; Lorenz, RL; Riesner, H; Weber, PC | 1 |
| Earl, CQ; Egan, JW; Smith, EF | 1 |
| Vallance, P | 1 |
| Frishman, WH; Miller, KP | 1 |
| Aliavi, AL | 1 |
| Ding, YA; Shieh, SM; Tung, CS | 1 |
| Peskar, BA; Simmet, T | 1 |
| Edhag, O; Green, K; Henriksson, P; Vesterqvist, O; Wennmalm, A | 1 |
| Beitz, H; Beitz, J; Hildebrandt, R; Kahl, PE; Mest, HJ; Mrochen, H; Schimke, E; Schimke, I | 1 |
| Abe, H; Inui, M; Kuzuya, T; Matsuda, H; Tada, M | 1 |
| Ito, T; Ogawa, K | 1 |
| Courillon-Mallet, A; Wautier, JL | 1 |
| Bernini, W; De Caterina, R; Donato, L; Filabozzi, P; Gazzetti, P; Giannessi, D; L'Abbate, A; Michelassi, C; Patrignani, P; Patrono, C | 1 |
| Evers, AS; Jakschik, BA; Murphree, S; Needleman, P; Saffitz, JE | 1 |
| Edhag, O; Green, K; Henriksson, P; Vesterqvist, O | 1 |
| Abe, H; Hoshida, S; Inoue, M; Kuzuya, T; Minamino, T; Tada, M | 1 |
7 review(s) available for thromboxanes and Cardiovascular Stroke
| Article | Year |
|---|---|
Platelet consumption in cardiovascular disease.
Topics: Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cardiovascular Diseases; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Heart Valve Diseases; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Rabbits; Radionuclide Imaging; Thromboembolism; Thrombosis; Thromboxanes | 1982 |
Prostaglandins, platelets, and atherosclerosis.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Circulation; Blood Vessels; Carotid Artery Thrombosis; Cyclooxygenase Inhibitors; Dogs; Epoprostenol; Female; Humans; Infusions, Parenteral; Male; Mice; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Rabbits; Rats; Structure-Activity Relationship; Thromboembolism; Thromboxane A2; Thromboxanes | 1980 |
[Interrelationships between the hemostatic system and the prostaglandin system in the pathogenesis of ischemic cardiopathy].
Topics: Angina Pectoris; Blood Coagulation Disorders; Blood Platelet Disorders; Coronary Disease; Coronary Vasospasm; Fibrinopeptide A; Humans; Myocardial Infarction; Prostaglandins; Thromboxanes | 1981 |
The case of low-dose aspirin for the prevention of myocardial infarction: but how low is low?
Topics: Aspirin; Coronary Disease; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Thromboxanes | 1997 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
Eicosanoids and the coronary circulation.
Topics: Anaphylaxis; Animals; Coronary Circulation; Coronary Disease; Epoprostenol; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Platelet Activating Factor; Thromboxanes | 1986 |
[Analogs of prostaglandin-related substances and inhibitors of their synthesis and metabolism. Clinical application: cardiovascular diseases].
Topics: Angina Pectoris; Aspirin; Coronary Disease; Epoprostenol; Humans; Hypertension; Methacrylates; Myocardial Infarction; Oxidoreductases; Platelet Aggregation; Thromboxane-A Synthase; Thromboxanes; Urokinase-Type Plasminogen Activator | 1985 |
10 trial(s) available for thromboxanes and Cardiovascular Stroke
| Article | Year |
|---|---|
Determinants of cardiovascular stability during abdominal aortic aneurysmectomy (AAA).
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Blood Platelets; Epoprostenol; Female; Heart; Hematologic Tests; Hemodynamics; Humans; Ibuprofen; Ligation; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Pulmonary Wedge Pressure; Serotonin; Thromboxane A2; Thromboxanes | 1984 |
Reduced side effects by low dose of acetylsalicylic acid (ASA) in patients with myocardial infarction; estimations of serum thromboxane B2 and PGF2 alpha.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dinoprost; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prostaglandins F; Thromboxane B2; Thromboxanes | 1984 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with Aspirin.
Topics: Aprotinin; Aspirin; Blood Loss, Surgical; Coronary Artery Bypass; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Fibrinolytic Agents; Hemostatics; Humans; Intraoperative Care; Isoenzymes; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Placebos; Postoperative Hemorrhage; Prospective Studies; Reproducibility of Results; Risk Factors; Thromboxanes | 1998 |
Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phthalic Acids; Pilot Projects; Platelet Aggregation Inhibitors; Single-Blind Method; Thromboxanes | 1999 |
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus.
Topics: Adult; Antibodies, Antiphospholipid; Antigens; Aspirin; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Ischemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Stroke; Thromboxane B2; Thromboxanes; Tissue Plasminogen Activator; Venous Thrombosis; von Willebrand Factor | 1999 |
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial.
Topics: Aged; Aspirin; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Streptokinase; Thromboxane A2; Thromboxane B2; Thromboxanes | 2001 |
[Pharmacological correction by roxicam of the prostacyclin-thromboxane system in acute myocardial infarction complicated by heart failure].
Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiac Glycosides; Diuretics; Epoprostenol; Heart Failure; Humans; Myocardial Infarction; Nitrates; Piroxicam; Thromboxane A2; Thromboxane B2; Thromboxanes | 1991 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
[Therapeutic prospects and prostaglandins in vascular pathology].
Topics: Angina Pectoris; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteritis; Aspirin; Blood Platelets; Cardiovascular Diseases; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Male; Myocardial Infarction; Prostaglandins; Raynaud Disease; Thromboxanes | 1985 |
39 other study(ies) available for thromboxanes and Cardiovascular Stroke
| Article | Year |
|---|---|
Leukotrienes and residual inflammatory risk in coronary artery disease.
Topics: Coronary Artery Disease; Humans; Leukotrienes; Myocardial Infarction; Thromboxanes | 2018 |
[Hormonal and Metabolic Differences in Patients With Coronary Artery Disease].
Topics: beta-Thromboglobulin; Coronary Artery Disease; Humans; Male; Myocardial Infarction; Norepinephrine; Thromboxanes | 2015 |
The autoantibody expression against different source of oxidized low density lipoprotein in patients with acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Case-Control Studies; Copper Sulfate; Epoprostenol; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Thromboxanes; Triglycerides | 2002 |
Aspirin resistance: a worry?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Drug Resistance; Fibrinolytic Agents; Humans; Myocardial Infarction; Stroke; Thromboxanes | 2005 |
[Biochemistry of coronary artery disease--prostaglandins].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Angina Pectoris; Epoprostenol; Humans; Middle Aged; Myocardial Infarction; Radioimmunoassay; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
[Problems of intravascular blood coagulation and thrombus formation in ischemic heart disease].
Topics: Blood Coagulation; Coronary Disease; Disseminated Intravascular Coagulation; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis; Thromboxanes | 1984 |
Thromboxane A2 in acute myocardial infarction.
Topics: Animals; Coronary Vessels; Dogs; Humans; Middle Aged; Myocardial Infarction; Streptokinase; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions.
Topics: Acetaminophen; Adult; Amino Acid Metabolism, Inborn Errors; Aspirin; Circadian Rhythm; Diabetes Mellitus; Female; Humans; Indomethacin; Male; Myocardial Infarction; Physical Exertion; Pregnancy; Reference Values; Thromboxane B2; Thromboxanes | 1984 |
The effect of prolonged treatment with sulphinpyrazone on thromboxane A2 and prostacyclin in man.
Topics: Adult; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Male; Myocardial Infarction; Prostaglandins; Sulfinpyrazone; Thromboxane A2; Thromboxanes | 1982 |
Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction.
Topics: Blood Platelets; Epoprostenol; Humans; Myocardial Infarction; Thromboxane B2; Thromboxanes | 1981 |
The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic disease. Resistance vessel-spasm hypothesis of ischemic disease.
Topics: Animals; Blood Platelets; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Coronary Vessels; Hemostasis; Homeostasis; Humans; Myocardial Infarction; Prostaglandin Antagonists; Prostaglandins; Thromboxanes; Vascular Resistance; Vasoconstriction; Vasodilation | 1982 |
Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat.
Topics: Animals; Aspirin; Collagen; Coronary Vessels; Dose-Response Relationship, Drug; Eicosanoids; Endothelium; Epoprostenol; Fibrosis; Heart; Ligation; Male; Myocardial Infarction; Rats; Rats, Wistar; Thromboxanes; Ventricular Function, Left | 1995 |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E | 2002 |
Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
Topics: Adult; Arachidonic Acids; Aspirin; Blood Platelets; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Malonates; Malondialdehyde; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1979 |
Effects of all cis-5,8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregation.
Topics: Adenosine Diphosphate; Arachidonic Acids; Collagen; Drug Interactions; Eicosanoic Acids; Fatty Acids, Unsaturated; Feeding Behavior; Humans; Inuit; Linoleic Acids; Linolenic Acids; Myocardial Infarction; Oleic Acids; Platelet Aggregation; Prostaglandins D; Prostaglandins E; Prostaglandins F, Synthetic; Thromboxanes | 1979 |
Thromboxane generation and platelet aggregation in survivals of myocardial infarction.
Topics: Adult; Aged; Arachidonic Acids; Blood Cell Count; Blood Platelets; Cholesterol; Humans; Indomethacin; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxane A2; Thromboxanes; Triglycerides | 1978 |
Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
Topics: Adult; Aged; Arachidonic Acids; Blood Platelets; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1978 |
[Development of myocardial infarction in aspirin-treated unstable angina pectoris. Repeated studies of platelet aggregation and of the thromboxane-prostacyclin system].
Topics: Adult; Angina, Unstable; Aspirin; Epoprostenol; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxanes | 1992 |
[Primary prostaglandins PGE2, PGF2, prostacyclin and thromboxane in patients with myocardial infarction].
Topics: Adult; Aged; Arrhythmias, Cardiac; Dinoprost; Dinoprostone; Epoprostenol; Fatty Acids, Unsaturated; Female; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values; Thromboxanes | 1992 |
Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Streptokinase; Thrombolytic Therapy; Thromboxane B2; Thromboxanes | 1992 |
[Plasma prostacyclin and thromboxane concentration in healthy children and in offspring of parents suffering from myocardial infarct].
Topics: Adolescent; Child; Child, Preschool; Epoprostenol; Female; Humans; Male; Myocardial Infarction; Prostaglandins F; Radioimmunoassay; Sex Factors; Thromboxanes | 1991 |
Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction.
Topics: Adult; Arachidonic Acids; Blood Platelet Disorders; Blood Platelets; Chromatography, Thin Layer; Dinoprostone; Humans; Lipoxygenase; Male; Myocardial Infarction; Platelet Aggregation; Prostaglandin D2; Thromboxanes | 1991 |
Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
Topics: Animals; Carbazoles; Coronary Circulation; Dogs; Female; Hemodynamics; Humans; Infusions, Intravenous; Ligation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Sulfonamides; Thromboxanes; Time Factors; Ventricular Fibrillation | 1991 |
Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction.
Topics: Adult; Aged; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2; Thromboxanes | 1990 |
Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbazoles; Coronary Disease; Coronary Vessels; Disease Models, Animal; Dogs; Hemodynamics; Myocardial Infarction; Prostaglandin Endoperoxides, Synthetic; Sulfonamides; Swine; Thromboxanes; Vasoconstriction | 1990 |
A prospective study of the diagnostic value of urinary thromboxane in patients presenting with acute chest pain.
Topics: Aged; Angina Pectoris; Angiography; Coronary Disease; Diagnosis, Differential; Emergencies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Prospective Studies; Thromboxanes | 1990 |
[Acetylsalicylic acid and myocardial infarction. Intermittent dosage means intact production of prostacyclin].
Topics: Aged; Aspirin; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Thromboxanes | 1989 |
BM 13.505, a selective thromboxane receptor antagonist, reduces myocardial infarct size following coronary artery reperfusion.
Topics: Animals; Cells, Cultured; Coronary Circulation; Coronary Vessels; Cytosol; Male; Myocardial Infarction; Myocardial Reperfusion; Phenylacetates; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes | 1989 |
Deficient prostacyclin formation after acute myocardial infarction.
Topics: 6-Ketoprostaglandin F1 alpha; Epoprostenol; Humans; Myocardial Infarction; Thromboxanes | 1987 |
Aspirin, infarction, and platelet/vessel-wall interactions.
Topics: Aspirin; Blood Platelets; Endothelium, Vascular; Epoprostenol; Humans; Myocardial Infarction; Thromboxanes | 1988 |
[Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Blood Platelets; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxane B2; Thromboxanes; Time Factors | 1988 |
[Platelet function in patients with acute myocardial infarction].
Topics: Aged; Angiotensin II; Blood Platelets; Epinephrine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxanes | 1988 |
In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.
Topics: 6-Ketoprostaglandin F1 alpha; Epoprostenol; Humans; Infusions, Parenteral; Myocardial Infarction; Thromboxane B2; Thromboxanes | 1986 |
The influence of cod-liver oil diet on various lipid metabolism parameters, the thromboxane formation capacity, platelet function and the serum MDA level in patients suffering from myocardial infarction.
Topics: Cholesterol; Cod Liver Oil; Fish Oils; Humans; Lipids; Lipoproteins; Male; Malonates; Malondialdehyde; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxanes; Triglycerides | 1987 |
Development of quantitative analysis of plasma thromboxane B2 by gas chromatography-mass spectrometry.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Angina Pectoris; Coronary Vasospasm; Dinoprost; Dinoprostone; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Myocardial Infarction; Organosilicon Compounds; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Prostaglandins F; Silicon; Thromboxane B2; Thromboxanes | 1985 |
Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction.
Topics: Aged; Aspirin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1985 |
Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction.
Topics: Animals; Chromatography, High Pressure Liquid; Coronary Circulation; Guinea Pigs; Ileum; Male; Muscle Contraction; Myocardial Infarction; N-Formylmethionine Leucyl-Phenylalanine; Prostaglandins; Rabbits; Radioimmunoassay; SRS-A; Thromboxanes; Vascular Resistance | 1985 |
In vivo production of thromboxane in acute human myocardial infarction: a preliminary study.
Topics: Aged; Female; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Male; Middle Aged; Myocardial Infarction; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |
Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction.
Topics: Acrylates; Creatine Kinase; Electrocardiography; Female; Humans; Male; Methacrylates; Middle Aged; Myocardial Infarction; Oxidoreductases; Prognosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1985 |